Reading Time: 6 minutesIt’s that time of year again when we’re counting down to the annual International Symposium on ALS/MND! This year marks the 35th Symposium, the largest scientific
Search Results for: mnd register
Reading Time: 6 minutesPlease note that this blog talks about sensitive topics such as death and tissue donation throughout. Researchers use many different tools to increase our understanding
Symposium Preview: Meet the ALS/MND Plenary Speakers…Part 2
Reading Time: 7 minutesEach year we invite plenary speakers who are experts in their fields to provide an overview on topics across MND research and clinical practice. This year we have 14 plenary speakers talking about ALS/MND who will discuss a wide range of topics from genetics to tissue biomarkers to improving clinical practice. In this second blog we will be taking a closer look at some of our plenary speakers this year and sharing more about the topics they will be discussing.
Symposium Preview: Meet the ALS/MND Plenary Speakers…Part 1
Reading Time: 7 minutesAs the research team count down to this year’s International Symposium on ALS/MND, we will be posting blogs throughout November to give you a snapshot
Reading Time: 7 minutesClinical trials are vital in the hunt for effective treatments of motor neurone disease. They provide the evidence needed to determine whether a drug is
Reading Time: 5 minutesThe current pace of clinical trials means that there are now more trials testing potential drugs for MND in the UK than ever before. One
Reading Time: 5 minutesThe pace of MND research continues to increase, with more clinical trials underway in the UK, over the last year, than ever before. Adding to this momentum, the clinical platform trial MAGNET (Multi-arm, Adaptive, Group-sequential trial NETwork)has just opened to recruitment in the UK.
Over the last several decades, there have been over 140 clinical trials for MND and unfortunately most of these have not led to effective treatments. More recently, clinical trial design has become more innovative, including the use of platform trials. MAGNET is a platform trial which aims to accelerate the development of new potential treatments for MND by testing multiple drugs simultaneously.
Reading Time: 4 minutesA new clinical trial, investigating Dazucorilant, for the treatment of MND is now open for recruitment in the UK. With this trial, there are now
Reading Time: 2 minutesResearchers from King’s College London have recently completed a study looking into different variations (a change or mistake) within the SOD1 gene and found that understanding the position and type of change within the gene can help to predict onset and progression of the disease.
Reading Time: 2 minutesThis blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Throughout November we’ve been counting down